Boston-based Activ Surgical designed ActivSight to provide enhanced visualization and real-time on-demand surgical insights in the operating room. The easy-to-adapt model seamlessly attaches to laparoscopic and robotic systems. It also integrates with standard monitors.
Activ Surgical received CE mark approval for ActivSight in December 2022. The FDA cleared the technology in April 2021.
The company aims to transform the surgical experience using emerging technologies and data. It wants every surgical imaging system to deliver intelligent information, reducing surgical complication rates.
About the first AI-enabled ActivSight Intelligent Light case for Activ Surgical
On Dec. 22, 2022, Dr. Matthew Kalady of The Ohio State University Wexner Medical Center used it in a laparoscopic left colectomy. The hospital’s chief of colon and rectal surgery removed the left side of the large bowel using the colorectal AI mode within ActivSight.
The company has an ongoing clinical study with Ohio State to evaluate the utility and usability of ActivSight.
“While using one of ActivSight’s intraoperative visual overlays, the dye-free ActivPerfusion Mode, I was able to clearly see key critical structures in the surgical site and tissue perfusion in real-time,” said Dr. Kalady. “With the press of a button, the colorectal AI mode was enabled, removing distractions of background signals from non-bowel tissue and clearly focusing on perfusion to the colon. There was a clear difference in visualization during AI mode.”
ActivPerfusion Mode utilizes laser speckle technology to show blood perfusion. Once enabled, the colorectal AI mode isolates the display to the targeted tissue. This minimizes cognitive burden for the surgeon.
“At Activ Surgical, we are driven to learn from every procedure using enhanced, real-time visualization capabilities combined with augmented reality, artificial intelligence and machine learning technology so that we can deliver intelligent information to doctors around the world to reduce surgical complication rates,” said Manisha Shah-Bugaj, the new CEO at Activ Surgical. “With this latest milestone, we usher in a new standard of patient care and safety and will continue to build on our progress using AI technology.”